New York State Common Retirement Fund’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-220
Closed -$455 3375
2024
Q2
$455 Sell
220
-13,862
-98% -$32.7K ﹤0.01% 3346
2024
Q1
$51.4K Sell
14,082
-28
-0.2% -$107 ﹤0.01% 2974
2023
Q4
$42.5K Sell
14,110
-58
-0.4% -$118 ﹤0.01% 3039
2023
Q3
$30.5K Buy
14,168
+268
+2% +$1.07K ﹤0.01% 3127
2023
Q2
$77.8K Buy
+13,900
New +$109K ﹤0.01% 3008
2022
Q3
Sell
-230
Closed -$1K 3483
2022
Q2
$1K Sell
230
-18,790
-99% -$70K ﹤0.01% 3431
2022
Q1
$119K Buy
19,020
+14,600
+330% +$149K ﹤0.01% 2984
2021
Q4
$50K Buy
+4,420
New +$84K ﹤0.01% 3221

Other funds holding OMGA

New York State Common Retirement Fund's OMGA Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q3 2024, closing a stake of 220 shares — an estimated $455 sold.

New York State Common Retirement Fund first reported a position in OMGA in Q4 2021 and held it in 8 quarters. The position peaked at $119K in Q1 2022. 54 funds tracked by Wall St. Rank hold OMGA as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 220 Omega Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $455.
  • New York State Common Retirement Fund first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • New York State Common Retirement Fund's Omega Therapeutics, Inc. Common Stock position peaked at $119K in Q1 2022.
  • 54 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.